Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda - Wikidata - awgldk - TriplyDB

Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda

Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda

http://www.wikidata.org/entity/Q28473126

about

Aggressive regimens for multidrug-resistant tuberculosis decrease all-cause mortality Programmatic Management of Drug-Resistant Tuberculosis: An Updated Research Agenda Assessing the impact of defining a global priority research agenda to address HIV-associated tuberculosis.Drug-resistant tuberculosis: a worldwide epidemic poses a new challenge Risk factors associated with MDR-TB at the onset of therapy among new cases registered with the RNTCP in Mumbai, India.Evaluation of tuberculosis diagnostics: establishing an evidence base around the public health impact.Linezolid manifests a rapid and dramatic therapeutic effect for patients with life-threatening tuberculous meningitis.Priorities for tuberculosis research: a systematic review.Research on implementation of interventions in tuberculosis control in low- and middle-income countries: a systematic review Building clinical trial capacity to develop a new treatment for multidrug-resistant tuberculosis.Setting priorities for a research agenda to combat drug-resistant tuberculosis in children Randomized clinical trials to identify optimal antibiotic treatment duration Mathematical models of the epidemiology and control of drug-resistant TB.Prevalence of pulmonary tuberculosis among prison inmates: A cross-sectional survey at the Correctional and Detention Facility of Abidjan, Côte d'Ivoire.Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study.Accelerating access to quality TB care for pediatric TB cases through better diagnostic strategy in four major cities of India.

P2860

Q28487938-4DC38B0C-DC2E-4EA3-8DAA-F3B47CDFE37A Q28552438-98B16C6E-58BD-49E2-9C3E-9382DBB0F14F Q30242038-05A4E955-7622-47A9-8F93-A90AD954E834 Q33595284-EC634950-781E-4F72-8781-162B5929FBB5 Q34043971-4364CEF9-84F2-480C-B9B7-432F9AD1C042 Q34224000-B1C41616-6D35-4226-86A1-10BCAB6C2640 Q34299173-87A923D8-AFEA-4561-A5A4-3962ABDC37AA Q34351616-DED7B414-4DF6-4C1A-A305-0030882DBAFA Q34524569-926A460B-EC61-4B9C-8431-892491F30708 Q35933528-D4F9AE95-7515-472F-B36D-4D19B1BB23F5 Q36380604-415656F4-EC62-496E-A29C-2686F5F549AA Q36755487-7A970B57-1B4D-4286-83B6-C58026C70DCF Q37754966-BCAB3474-1DA0-4D0B-B99F-7814F2AD9C6E Q39503800-F9048455-9D2E-4279-8A01-96A96719D47B Q42246655-CDFC3590-C287-4E80-AAAF-453A649A1B12 Q52681375-DA480C3C-6967-45B4-86C8-99F0EC036784

P2860

Scaling up programmatic management of drug-resistant tuberculosis: a prioritized research agenda

http://www.wikidata.org/entity/Q28473126

description

2008 nî lūn-bûn

@nan

2008 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2008 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

name

Scaling up programmatic manage ...... a prioritized research agenda

@ast

Scaling up programmatic manage ...... a prioritized research agenda

@en

Scaling up programmatic manage ...... a prioritized research agenda

@nl

type

label

Scaling up programmatic manage ...... a prioritized research agenda

@ast

Scaling up programmatic manage ...... a prioritized research agenda

@en

Scaling up programmatic manage ...... a prioritized research agenda

@nl

prefLabel

Scaling up programmatic manage ...... a prioritized research agenda

@ast

Scaling up programmatic manage ...... a prioritized research agenda

@en

Scaling up programmatic manage ...... a prioritized research agenda

@nl

P1433

Q28473126-C2A1DE10-9942-4534-AC25-A2B97CDAC5C1

P1476

Q28473126-3BFFDEC0-8DCB-435A-AB4F-AB68862C2938

P2093

Q28473126-07C97C6E-D6BA-41EA-BD9E-D47FB3D9F333

Q28473126-0D8E11AE-7563-4320-89A0-510749B9224F

Q28473126-4D18B724-3740-470C-8355-47C3403ED72C

Q28473126-64C760B8-8180-45F0-BB2C-94DA056A2A5A

Q28473126-74D65CD2-7BD3-4DFE-BB21-65D2AC804608

Q28473126-86D0CF84-639D-454A-944A-E73D3B7C2F53

Q28473126-994A62D6-8FAF-4204-88DD-421EF9F8EDAE

Q28473126-9DCF2C2B-13AE-4184-A439-742F55C3B763

Q28473126-D12B2BDC-D98A-4553-A971-8943FF2BC69B

P2860

Q28473126-04CF6562-68D5-4FE9-9FBE-9A3273EBE2D2

Q28473126-0B3EB566-1457-42EB-8132-36C95B7C1425

Q28473126-17077500-04BC-46D0-9AA0-5E1F764016F2

Q28473126-17EEE233-D64D-47AA-9301-0B1BA9D150E4

Q28473126-1861433A-3075-4309-A3B3-5A2F08617DE0

Q28473126-1DD5CC1C-6E8C-4BF9-B0F3-06662274C5C6

Q28473126-1E54C8C4-8572-4225-95C0-5F4B997C29B6

Q28473126-26A8B1AD-1EDB-4CD5-938E-60FF7A262022

Q28473126-2B0302A2-283F-463B-A871-9056774C90B1

Q28473126-2B40DAB8-AA0D-4A32-8351-5683B8F01193

P304

Q28473126-F6597358-8BF6-470A-AA42-7A72DAAE20D1

P31

Q28473126-CF0A671C-DE92-4453-BE70-14E6CAFF8503

P3181

Q28473126-08434365-5BB4-44B2-85C3-A6EE382D51B5

P356

Q28473126-BD0D446F-D9F6-4D50-A53B-68F620FD7C5D

P407

Q28473126-7ABBFC47-B17C-4687-949C-EF33C6A1EE9A

P433

Q28473126-18563F7A-FCBB-47D1-A987-CB235F226A64

P478

Q28473126-A0577653-0042-43B7-A8F5-BC3AF1F53E1E

P577

Q28473126-7FD9AC3B-279A-44A8-ACB2-2B2352026781

P5875

Q28473126-6DD6EF16-7DFB-4AB1-B51E-9EA1942534BD

P698

Q28473126-B9AD8C09-0053-4BD8-A977-07629F1D9D38

P921

Q28473126-1A3F3A05-1F13-445A-A1C7-5D8E54BCA75C

P932

Q28473126-5BF7E695-7377-47F4-8636-82624207177C

P3181

P356

JOURNAL.PMED.0050150

P1433

P1476

Scaling up programmatic manage ...... a prioritized research agenda

@en

P2093

Carole D Mitnick

http://www.w3.org/2001/XMLSchema#string

Einar Heldal

http://www.w3.org/2001/XMLSchema#string

Frank G J Cobelens

http://www.w3.org/2001/XMLSchema#string

Hans L Rieder

http://www.w3.org/2001/XMLSchema#string

Karin Weyer

http://www.w3.org/2001/XMLSchema#string

Laura J Podewils

http://www.w3.org/2001/XMLSchema#string

Matteo Zignol

http://www.w3.org/2001/XMLSchema#string

Michael E Kimerling

http://www.w3.org/2001/XMLSchema#string

Rajeswari Ramachandran

http://www.w3.org/2001/XMLSchema#string

P2860

Natural ventilation for the prevention of airborne contagion

Studies on the treatment of tuberculosis undertaken by the British Medical Research Council tuberculosis units, 1946-1986, with relevant subsequent publications

Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America

Community-based therapy for multidrug-resistant tuberculosis in Lima, Peru

Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa

Clinical outcome of individualised treatment of multidrug-resistant tuberculosis in Latvia: a retrospective cohort study

Cost-effectiveness of treating multidrug-resistant tuberculosis

Feasibility and cost-effectiveness of treating multidrug-resistant tuberculosis: a cohort study in the Philippines

Update: adverse event data and revised American Thoracic Society/CDC recommendations against the use of rifampin and pyrazinamide for treatment of latent tuberculosis infection--United States, 2003.

Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug r

P304

e150

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1377365

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PMED.0050150

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2008-07-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5238546

http://www.w3.org/2001/XMLSchema#string

P698

18613746

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

P932

2443187

http://www.w3.org/2001/XMLSchema#string